Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07472842
Recruiting Not applicable

Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected Pelvic Endometriosis

NCT07472842 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-10-16
Last updated
2026-08-26

Condition(s) studied

EndometriosisPelvic Pain SyndromeChronic Gynaecological Disease

Investigational drug(s) / intervention(s)

Emergency care for endometriosis

Emergency care for endometriosis: Emergency care for endometriosis * Introduction of specific treatment for endometriosis * Scheduled or completed specialist consultation (gynecologist, surgeon, midwife, radiologist) * Pelvic imaging examination scheduled or completed since the gynecological emergency consultation

Study summary

Adult patients consulting the gynecological emergency department of CHI Créteil during the inclusion period for endometriosis or symptoms suggestive of endometriosis

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria : * Adult patient (aged 18 or over) * Patient consulting the gynecological emergency department at Créteil Hospital for * Known endometriosis or * Symptoms suggestive of endometriosis: dysmenorrhea, pelvic pain, cyclic dysuria, dyspareunia, cyclic dyschezia, infertility, rectal bleeding, chest pain, catamenial hematuria * Patient who speaks French and is able to understand the information sheet Exclusion Criteria: * Minor or menopausal patient * Pregnant and breastfeeding patient * Other reason for consultation * Patient refusal * Patient not affiliated with a social security system * Patient cannot be contacted for the 3-months questionnaire

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHI Créteil Créteil France Recruiting

More Centre Hospitalier Intercommunal Creteil trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07472842 on ClinicalTrials.gov ↗ ← All trials in France